National Bank of Canada
GLSI icon

National Bank of Canada’s Greenwich LifeSciences GLSI Stock Holding History

National Bank of Canada’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328 Buy
+14
New +$341 ﹤0.01% 2906

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

National Bank of Canada's GLSI Position: Q2 2026 in Review

National Bank of Canada opened a new position in Greenwich LifeSciences (GLSI) in Q2 2026: 14 shares worth $328. The stake represents ﹤0.01% of the portfolio and ranks #2906 among its holdings.

58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • National Bank of Canada held 14 shares of Greenwich LifeSciences worth $328 as of Q2 2026.
  • Greenwich LifeSciences was a new National Bank of Canada position in Q2 2026.
  • Greenwich LifeSciences made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #2906 holding.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.